# Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas

> **NCT00942760** · — · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Recurrent High Grade Gliomas

## Interventions

- **DEVICE:** 3T MRI

## Key facts

- **NCT ID:** NCT00942760
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942760, "Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00942760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*